The effect of ziprasidone and risperidone on schizophrenia patients and the change of leptin ,adiponectin levels / 国际检验医学杂志
International Journal of Laboratory Medicine
; (12): 506-507,510, 2016.
Article
em Zh
| WPRIM
| ID: wpr-603651
Biblioteca responsável:
WPRO
ABSTRACT
Objective To observe the effects of ziprasidone and risperidone on schizophrenia patients and the change of serum leptin and adiponectin levels .Methods Totally 80 cases of schizophrenia patients were randomly divided into ziprasidone group and risperidone group ,which were treated for 8 weeks .Measure the positive and negative symptoms scale (PANSS) score and body weight of that number ,leptin and adiponectin at baseline ,treatment 4 weeks and 8 weeks respectively for patients ,at the end of the experiment ,the results for statistical analysis .Results Two groups of 4 ,8 weeks after treatment scores compared with baseline scores dropped significantly ,the difference was statistically significant(P<0 .05) .Risperidone group after treatment ,leptin levels significantly increased body mass index ,and adiponectin levels significantly decreased ,compared with the baseline before treatment was statistically significant difference(P<0 .05) .Conclusion Ziprasidone and risperidone in treatment of schizophrenia have similar efficacy .Ziprasidone has no significant effect on body weight ,leptin and adiponectin levels in treatment of schizophrenia patients . However ,risperidone has a significant effect ,long-term use should pay attention to the side effects .
Texto completo:
1
Base de dados:
WPRIM
Idioma:
Zh
Revista:
International Journal of Laboratory Medicine
Ano de publicação:
2016
Tipo de documento:
Article